Skip to main content

2 Result(s)

within Article Remove this filter Natalia A. Rocha Remove this filter

and

  1. No Access

    Article

    ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen

    Apolipoprotein CIII (ApoCIII) is now recognized as a key regulator in severe hypertriglyceridemia, chylomicronemia, and conditions of triglyceride-rich lipoprotein (TRL) remnant excess due to its inhibition of...

    Natalia A. Rocha, Cara East, Jun Zhang… in Current Atherosclerosis Reports (2017)

  2. Article

    Open Access

    Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report

    Denosumab and abiraterone were approved by the United States Food and Drug Administration in 2011 for the treatment of metastatic castration-resistant prostate cancer. Neither denosumab nor abiraterone is know...

    Javier A. Neyra, Natalia A. Rocha, Rhea Bhargava, Omkar U. Vaidya… in BMC Nephrology (2015)

    Download PDF (841 KB) View Article